These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6874588)

  • 1. Vanoxonin, a new inhibitor of thymidylate synthetase.
    Kanai F; Sawa T; Hamada M; Naganawa H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1983 Jun; 36(6):656-60. PubMed ID: 6874588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vanoxonin, a new inhibitor of thymidylate synthetase. III. Inhibition of thymidylate synthetase by vanoxonin-vanadium complex.
    Kanai F; Kaneko T; Morishima H; Isshiki K; Takita T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1985 Jan; 38(1):39-50. PubMed ID: 3972727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vanoxonin, a new inhibitor of thymidylate synthetase. II. Structure determination and total synthesis.
    Kanai F; Isshiki K; Umezawa Y; Morishima H; Naganawa H; Takita T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1985 Jan; 38(1):31-8. PubMed ID: 3972726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic inhibitors of Escherichia coli, calf thymus, and Ehrlich ascites tumor thymidylate synthetase.
    Kampf A; Barfknecht RL; Shaffer PJ; Osaki S; Mertes MP
    J Med Chem; 1976 Jul; 19(7):903-8. PubMed ID: 781246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of mammalian tumour thymidylate synthetase by 5-alkylated 2'-deoxyuridine 5'-phosphates.
    Rode W; Kulikowski T; Kedzierska B; Jastreboff M; Shugar D
    Biochem Pharmacol; 1984 Sep; 33(17):2699-705. PubMed ID: 6466380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidylate synthetase inhibitors. Synthesis of N-substituted 5-aminomethyl-2'-deoxyuridine 5'-phosphates.
    Edelman MS; Barfknecht RL; Huet-Rose R; Boguslawski S; Mertes MP
    J Med Chem; 1977 May; 20(5):669-73. PubMed ID: 323484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered thymidylate synthetase in 5-fluorodeoxyuridine-resistant Ehrlich ascites carcinoma cells.
    Jastreboff MM; Kedzierska B; Rode W
    Biochem Pharmacol; 1983 Jul; 32(14):2259-67. PubMed ID: 6223641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thymidylate synthetase by the new quinazoline antifolate, CB 3717; enzyme purification and kinetics.
    Jackman AL; Calvert AH; Hart LI; Harrap KR
    Adv Exp Med Biol; 1984; 165 Pt B():375-8. PubMed ID: 6720434
    [No Abstract]   [Full Text] [Related]  

  • 9. Thymidylate synthetase-positive and -negative murine mammary FM3A carcinoma cells as a useful system for detecting thymidylate synthetase inhibitors.
    Balzarini J; de Clercq E; Ayusawa D; Seno T
    FEBS Lett; 1984 Jul; 173(1):227-32. PubMed ID: 6745430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of thymidylate synthetase from Ehrlich ascites carcinoma cells. Effect of Mg2/ and MgATP2-.
    Jastreboff M; Kedzierska B; Rode W
    Biochem Pharmacol; 1982 Jan; 31(2):217-23. PubMed ID: 6977362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Mg2+ and adenine nucleotides on thymidylate synthetase from different mouse tumors.
    Rode W; Jastreboff MM
    Mol Cell Biochem; 1984; 60(1):73-6. PubMed ID: 6231470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-(( 2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino) benzoyl)-L-glutamic acid (CB3717), on human lymphoblastoid cells.
    Jackson RC; Jackman AL; Calvert AH
    Biochem Pharmacol; 1983 Dec; 32(24):3783-90. PubMed ID: 6661252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma nucleoside and base levels following treatment with the new thymidylate synthetase inhibitor CB 3717.
    Taylor GA; Jackman AL; Calvert AH; Harrap KR
    Adv Exp Med Biol; 1984; 165 Pt B():379-82. PubMed ID: 6720435
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of thymidylate synthetase of the human lymphocytes.
    Haurani FI
    Cancer Biochem Biophys; 1979; 4(2):75-7. PubMed ID: 317899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. trans-5-(3,3,3-Trifluoro-1-propenyl-)-2'-deoxyuridylate: a mechanism-based inhibitor of thymidylate synthetase.
    Wataya Y; Matsuda A; Santi DV; Bergstrom DE; Ruth JL
    J Med Chem; 1979 Apr; 22(4):339-40. PubMed ID: 430474
    [No Abstract]   [Full Text] [Related]  

  • 16. Inactivation of thymidylate synthetase by a novel mechanism-based enzyme inhibitor: 1-(beta-D-2'-deoxyribofuranosyl) 8-azapurin-2-one 5'-monophosphate.
    Kalman TI; Goldman D
    Biochem Biophys Res Commun; 1981 Sep; 102(2):682-9. PubMed ID: 6796091
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytotoxicity of 5-nitro-2'-deoxyuridine by in vivo inhibition of thymidylate synthetase.
    Washtien W; Matsuda A; Wataya Y; Santi DV
    Biochem Pharmacol; 1978; 27(22):2663-6. PubMed ID: 215163
    [No Abstract]   [Full Text] [Related]  

  • 18. Purification and characterization of thymidylate synthetase in the liver of the mouse bearing Ehrlich ascites tumor.
    Asanagi M; Moriyama Y; Fujimura S
    Arch Biochem Biophys; 1988 Dec; 267(2):749-57. PubMed ID: 3214180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved measurement of thymidylate synthetase activity by a modified tritium-release assay.
    Armstrong RD; Diasio RB
    J Biochem Biophys Methods; 1982 Jun; 6(2):141-7. PubMed ID: 7108126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potent multisubstrate analogue inhibitor of human thymidylate synthetase.
    Srinivasan A; Amarnath V; Broom AD; Zou FC; Cheng YC
    J Med Chem; 1984 Dec; 27(12):1710-7. PubMed ID: 6502602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.